W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
Safety, Pharmacokinetics and Biological Activity of Enlimomab (Anti-ICAM-1 Antibody): An Open-Label, Dose Escalation Study in Patients Hospitalized for Acute Stroke
Dietmar Schneider,J. Berrouschot,T. Brandt,Werner Hacke,A. Ferbert,S.H. Norris,S.H. Polmar,E. Schäfer +7 more
TL;DR: Doses of enlimomab between 140 and 480 mg administered over 5 days did not increase the risk of adverse events in patients with ischaemic or haemorrhagic stroke during an observation period of 30 ± 10 days.
Journal ArticleDOI
The Carotid Surgery for Ischemic Stroke trial: A prospective observational study on carotid endarterectomy in the early period after ischemic stroke
Hans-Henning Eckstein,Peter A. Ringleb,Arnd Dörfler,K. Klemm,B.T. Müller,M. Zegelman,Hubert J. Bardenheuer,Werner Hacke,T. Bruckner,W. Sandmann,Jens-Rainer Allenberg +10 more
TL;DR: Early CEA within 6 weeks after a carotid-related ischemic stroke can be performed with a perioperative stroke or mortality rate comparable with the results reported in the European Carotid Surgery Trial and the North American Symptomatic Carotids Endarterectomy Trial.
Journal ArticleDOI
Thrombolytic intervention in acute thrombotic and embolic stroke.
TL;DR: In this article, the authors focused on the possible value of fibrinolytic therapy in acute stroke and evaluated fibrinoblastoma multiforme (FMB) and tissue plasminogen activators.
Journal ArticleDOI
Spontaneous resolution of a large spinal epidural hematoma: case report.
TL;DR: This case of spontaneous spinal epidural hematoma that was probably associated with aspirin intake is reported, remarkable for dramatic clinical improvement within 12 hours and the magnetic resonance imaging documentation of complete resolution within 3 days.
Journal ArticleDOI
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
Keith A.A. Fox,Joseph E. Lucas,Karen S. Pieper,Jean-Pierre Bassand,A. John Camm,David Fitzmaurice,Samuel Z. Goldhaber,Shinya Goto,Sylvia Haas,Werner Hacke,Gloria Kayani,Ali Oto,Lorenzo G. Mantovani,Frank Misselwitz,Jonathan P. Piccini,Alexander G.G. Turpie,Freek W.A. Verheugt,Ajay K Kakkar +17 more
TL;DR: The GARFIELD-AF risk tool was superior to CHA2DS2-VASc in predicting stroke and mortality and superior to HAS-BLED for bleeding, overall and in lower risk patients, and has the potential for incorporation in routine electronic systems.